An A > G polymorphism at position - 670 in the Fas (TNFRSF6) gene in pregnant women with pre-eclampsia and intrauterine growth restriction

Molecular Human Reproduction

Volumn 11, Issue 3, 2005, Pages 207-210

  Sziller, Istvan ^a   Nguyen, Daniel ^b   Halmos, Amrita ^a   Hupuczi, Petronella ^a   Papp, Zoltan ^a   Witkin, Steven S ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Fas; Genetic polymorphism; Intrauterine growth restriction; Pre eclampsia; TNFRSF6

Indexed keywords

ADENINE; FAS LIGAND; GUANINE;

ADULT; APOPTOSIS; ARTICLE; CHEEK MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GESTATIONAL AGE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUNGARY; INTRAUTERINE GROWTH RETARDATION; LYMPHOCYTE; NEWBORN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RISK ASSESSMENT;

ADULT; ANTIGENS, CD95; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HUNGARY; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 18644369645     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah151     Document Type: Article

References (23)

1. Abrahams VM, Straszewski-Chavez SL, Guller S and Mor G (2004) First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10,55-63.
2. Allaire AD, Ballenger KA, Wells SR, McMahon MJ and Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol 96,271-276.
3. American College of Obstetricians and Gynecologists (2002) Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin no. 33. American Family Physician 66, 330-331.
4. Bamberger AM, Schulte HM, Thuneke I, Edrman I, Mamberger CM and Asa S (1997) Expression of apoptosis inducing Fas ligand (FasL) in human first and thrid trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82,3173-3175.
5. Bischof P, Meisser A and Campana A (2000) Paracrine and autocrine regulatorts of trophoblast invasion - a review. Placenta 21 (Suppl. A),S55-S60.
6. Cotter AM, Martin CM, O'Leary JJ and Daly SF (2004) Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol 191,515-520.
7. Genc MR, Gerber S, Nesin M and Witkin SS (2002) Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am J Obstet Gynecol 187,157-163.
8. Gerretsen G, Huisjes H and Elema JD (1981) Morpohological changes of the spiral arteries in the placenta bed in relation to preeclampsia and fetal growth retardation. Br J Obstet Gynecol 88,876-881.
9. Griffith TS, Brunner T, Fletcher SM, Green DR and Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270,1189-1192.
10. Kalish RB, Nguyen DP, Vardhana S, Gupta M, Perni SC and Witkin SS (2005) A single nucleotide A > G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rapture of fetal membranes in multifetal pregnancies. Am J Obstet Gynecol 192,208-212.
11. Koonin LM, MacKay AP, Berg CJ, Atrash HK and Smith JC (1997) Pregnancy-related mortality surveillance - United States, 1987-1990. MMWR Surveill Summ 46,17-36.
12. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ and DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248,220-223.
13. Lai H-C, Sytwu H-K, Sun C-A, Yu M-H, Yu C-P, Liu H-S, Chang CC and Chu TY (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103,221-225.
14. Lala PK and Graham CH (1990) Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer Metastasis Rev 9,369-379.
15. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ and Redman CWG (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45,184-188.
16. Ness RB and Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175,1365-1370.
17. Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, Mussi C, Ventura P, Olivieri F, Franceschi C et al. (2002) Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ 9,431-438.
18. Roberts JM and Redman CWG (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341,1447-1451.
19. Skjaerven R, Gjessing HK and Bakketeig LS (2000) Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand 79,440-449.
20. Vatten LJ and Skjaerven R (2004) Is pre-eclampsia more than one disease? Br J Obstet Gynecol 111,298-302.
21. Walker JJ (2000) Pre-eclampsia. Lancet 356,1260-1265.
22. Xiong X, Demianczuk ND, Saunders LD, Wang FL and Fraser WD (2002) Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 155,203-209.
23. Zhang BX, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D and Swain SL (1997) Unequal death in T helper cells (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185,1837-1849.